Follow the 窪田製薬ホールディングス株式会社 stock price and the full management transaction log of the company, a listed issuer based in Japan. Shares are listed on JP JP, under the supervision of EDINET (Japan FSA). Operating in the Health Care sector, 窪田製薬ホールディングス株式会社 has recorded 63 reports. Market capitalisation: €9.1bn. The latest transaction was disclosed on 14 July 2026 (Holding update). Among the most active insiders: Barclays Bank PLC. The full history is free.
63
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
17Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,456 of 28,207 companies
11.4
score / 100
Value
19
Quality
4
FCF yld-6.5%
Earn yld-7.4%
EV/EBITDA·
ROE-51%
Gross mgn-22%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Kubota Pharmaceutical Holdings Co., Ltd. is a Japanese company focused on the health and pharmaceutical sector. It specializes in the development of innovative treatments and therapeutic solutions.
